A. Iagaru

Stanford University

Poster Author Of 15 e-Posters

 Annual Meeting
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU 38

38 - Diagnostic Performance of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the Phase 3, Multicenter CONDOR Study (ID 1227)

Session Name
Prostate: PSMA PET in biochemical recurrence
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
38
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU 187

187 - 68Ga-PSMA-11 PET/MR Imaging before prostatectomy: correlation with surgical pathology and two-year follow up (ID 782)

Session Name
Prostate: PSMA PET and others
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
187
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine 306

306 - Extrahepatic 68Ga-DOTATATE-Avid Tumor Volume and serum Chromogranin A Predict Short-Term Outcome of 177Lu-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors (ID 310)

Session Name
Advances in Endo/Neuroendo Therapy
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine
Presentation Number
306
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Sarcoma/Melanoma 484

484 - Imaging characteristics and diagnostic performance of 18F-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy (ID 547)

Session Name
Sarcoma, Melanoma & Others
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Sarcoma/Melanoma
Presentation Number
484
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Sarcoma/Melanoma 489

489 - Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy (ID 546)

Session Name
Sarcoma, Melanoma & Others
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Sarcoma/Melanoma
Presentation Number
489
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Breast Cancer 550

550 - Prognostic values of quantitative and morphological parameters of dbPET in patients with luminal-type breast cancer: A pilot study (ID 843)

Session Name
Breast Cancer I
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Breast Cancer
Presentation Number
550
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU 1249

1249 - PSMA- and GRPR-targeted PET: Preliminary Results in Patients with Biochemically Recurrent Prostate Cancer (ID 797)

Session Name
GU - PSMA PET (Poster Session)
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
1249
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU 1261

1261 - 68Ga-RM2 PET/CT in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer (ID 790)

Session Name
GU - PSMA PET (Poster Session)
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
1261
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine 1438

1438 - Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A two-year single institution experience (ID 324)

Session Name
Endocrine/Neuroendocrine (Therapy/Non-Therapy) Poster Session
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine
Presentation Number
1438
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine 1442

1442 - Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs) (ID 325)

Session Name
Endocrine/Neuroendocrine (Therapy/Non-Therapy) Poster Session
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine
Presentation Number
1442
Physics, Instrumentation & Data Sciences -> Image Generation 1477

1477 - High Quality Isotropic Whole-body PET Imaging Using MR Priors (ID 198)

Session Name
Image Generation (Poster Session)
Speakers
Authors
Presentation Topic
Physics, Instrumentation & Data Sciences -> Image Generation
Presentation Number
1477
Cardiovascular -> Clinical Science 1605

1605 - A pilot study of 18F-FSPG SiPM-based PET/CT in patients referred for exclusion of active cardiac sarcoidosis and negative or non-diagnostic 18F-FDG PET/CT (ID 491)

Session Name
Clinical Science (Poster Session)
Speakers
Authors
Presentation Topic
Cardiovascular -> Clinical Science
Presentation Number
1605
Poster Award Finalist
Award Finalist
Clinical PET 3011

3011 - Determining optimal uptake time for 68Ga-labeled radiopharmaceuticals targeting gastrin-releasing peptide receptors with a modified NEMA phantom. (ID 611)

Session Name
Tech Papers II: Clinical PET Technologist Papers
Speakers
Authors
Presentation Topic
Clinical PET
Presentation Number
3011
Clinical PET 3016

3016 - Key components of a successful PET/MR department (ID 616)

Session Name
Tech Papers II: Clinical PET Technologist Papers
Speakers
Authors
Presentation Topic
Clinical PET
Presentation Number
3016
Clinical PET 3120

3120 - SUV measurements from images reconstructed with the block sequential regularized expectation maximization algorithm: comparison of motion corrected vs. non-motion corrected data (ID 662)

Session Name
Technologist Poster Session
Speakers
Authors
Presentation Topic
Clinical PET
Presentation Number
3120